about
Understanding the genetic architectonics of complex CNS traits: Lost by the association, but found in the interaction?Molecular psychiatry of zebrafish.The failure of anxiolytic therapies in early clinical trials: what needs to be done.14th Annual Meeting of the Safety Pharmacology Society: threading through scientific sessions for originality and novelty.Adult zebrafish in CNS disease modeling: a tank that's half-full, not half-empty, and still filling.
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Rethinking CNS disorders: time for new drug targets?
@en
Rethinking CNS disorders: time for new drug targets?
@nl
type
label
Rethinking CNS disorders: time for new drug targets?
@en
Rethinking CNS disorders: time for new drug targets?
@nl
prefLabel
Rethinking CNS disorders: time for new drug targets?
@en
Rethinking CNS disorders: time for new drug targets?
@nl
P1476
Rethinking CNS disorders: time for new drug targets?
@en
P2093
Adam Michael Stewart
Allan V Kalueff
P304
P356
10.1016/J.TIPS.2014.07.007
P577
2014-08-26T00:00:00Z